217 related articles for article (PubMed ID: 19286353)
1. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
[TBL] [Abstract][Full Text] [Related]
3. Cyp46 polymorphisms in Alzheimer's disease: a review.
Garcia AN; Muniz MT; Souza e Silva HR; da Silva HA; Athayde-Junior L
J Mol Neurosci; 2009 Nov; 39(3):342-5. PubMed ID: 19705089
[TBL] [Abstract][Full Text] [Related]
4. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.
Fourgeux C; Martine L; Björkhem I; Diczfalusy U; Joffre C; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5712-7. PubMed ID: 19553612
[TBL] [Abstract][Full Text] [Related]
5. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.
Papassotiropoulos A; Streffer JR; Tsolaki M; Schmid S; Thal D; Nicosia F; Iakovidou V; Maddalena A; Lütjohann D; Ghebremedhin E; Hegi T; Pasch T; Träxler M; Brühl A; Benussi L; Binetti G; Braak H; Nitsch RM; Hock C
Arch Neurol; 2003 Jan; 60(1):29-35. PubMed ID: 12533085
[TBL] [Abstract][Full Text] [Related]
6. Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease.
Johansson A; Katzov H; Zetterberg H; Feuk L; Johansson B; Bogdanovic N; Andreasen N; Lenhard B; Brookes AJ; Pedersen NL; Blennow K; Prince JA
Hum Genet; 2004 May; 114(6):581-7. PubMed ID: 15034781
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
8. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
9. An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.
He XM; Zhang ZX; Zhang JW; Zhou YT; Wu CB; Tang MN; Hong Z
J Mol Neurosci; 2012 Jul; 47(3):514-8. PubMed ID: 22528464
[TBL] [Abstract][Full Text] [Related]
10. RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Friedrichs S; Maier TA; Heun R
J Cell Mol Med; 2009 Mar; 13(3):589-98. PubMed ID: 19374686
[TBL] [Abstract][Full Text] [Related]
11. CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer's Disease.
Li L; Zeng F; Liu YH; Li HY; Dong SY; Peng ZY; Wang YJ; Zhou HD
Mol Neurobiol; 2018 Oct; 55(10):8179-8187. PubMed ID: 29516283
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease.
Kölsch H; Lütjohann D; Jessen F; Von Bergmann K; Schmitz S; Urbach H; Maier W; Heun R
Int J Mol Med; 2006 May; 17(5):791-4. PubMed ID: 16596262
[TBL] [Abstract][Full Text] [Related]
13. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population.
Ma SL; Tang NL; Lam LC; Chiu HF
Int Psychogeriatr; 2006 Mar; 18(1):37-45. PubMed ID: 16734927
[TBL] [Abstract][Full Text] [Related]
15. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease.
Papassotiropoulos A; Wollmer MA; Tsolaki M; Brunner F; Molyva D; Lütjohann D; Nitsch RM; Hock C
J Clin Psychiatry; 2005 Jul; 66(7):940-7. PubMed ID: 16013913
[TBL] [Abstract][Full Text] [Related]
16. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma.
Fourgeux C; Bron A; Acar N; Creuzot-Garcher C; Bretillon L
Chem Phys Lipids; 2011 Sep; 164(6):496-9. PubMed ID: 21531213
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
[TBL] [Abstract][Full Text] [Related]
18. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse.
Meljon A; Wang Y; Griffiths WJ
Biochem Biophys Res Commun; 2014 Apr; 446(3):768-74. PubMed ID: 24491562
[TBL] [Abstract][Full Text] [Related]
19. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
[TBL] [Abstract][Full Text] [Related]
20. CYP46A1 functional promoter haplotypes decipher genetic susceptibility to Alzheimer's disease.
Li Y; Chu LW; Wang B; Yik PY; Huriletemuer ; Jin DY; Ma X; Song YQ
J Alzheimers Dis; 2010; 21(4):1311-23. PubMed ID: 20693622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
